← Evidence map

ArticleAlimentary pharmacology & therapeutics2022

Editorial: intravenous to subcutaneous vedolizumab-switch without glitch!

Vinoth Nadesalingam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35748843